video corpo

Abbominal tissue matrix BIORIPAR Porcine Dermis

abbominal tissue matrix
abbominal tissue matrix
abbominal tissue matrix
Add to favorites
Compare this product


abbominal, pelvic
collagen, xenograft


Porcine dermis collagen membrane, subjected to a multiphase chemical treatment, conceived and developed in ASSUT EUROPE S.p.A. in order to: remove antigenicity inactivate any type of pathogen preserve the biomechanical properties ensure biocompatibility and the ability to remodel tissues obtaining the complete destruction of the cells and the subsequent removal of polluting cellular and protein residues, including: nucleic acids, keratin and fats, without altering the three-dimensional structure of the collagen in the material. 1. a form composed of type I and III collagen, and elastin, obtained by removing the hypodermis and epidermis, leaving the central layer of the dermis 2. a form reinforced with the basement membrane, composed of type IV and VII collagen The device acts as a matrix for the germination of fibroblasts, the formation of new tissues and blood vessels. Simultaneously with the creation of new tissues there is a gradual degradation of the collagen of the dermis. The porous structure of the native porcine dermis ensures long-term drainage. The most important feature of Bioripar Derma Porcino is its collagen structure (type I and III), which guarantees its stability while still being soft and flexible. The membrane is easily sutured. After the application, the collagen matrix repairs damaged surfaces. The body reacts to the introduction of collagen by starting the repair process of damaged tissues: it begins to release a large number of cytokines, growth factors, and gradually replaces the implanted material with healthy tissues.


7 Pages
*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.